PARISI, CLAUDIA
PARISI, CLAUDIA
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances
2021 Tateo, V.; Manuzzi, L.; Parisi, C.; De Giglio, A.; Campana, D.; Pantaleo, M. A.; Lamberti, G.
Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience
2024 Parisi, Claudia; Carlos Benitez, José; Lecourt, Hélène; Gustavo Dall'Olio, Filippo; Aldea, Mihaela; Blanc-Durand, Felix; Vergé, Véronique; Quivoron, Cyril; Naltet, Charles; Abdayem, Pamela; Lavaud, Pernelle; Rosa Ghigna, Maria; Friboulet, Luc; Loriot, Yohann; De Botton, Stéphane; Ribrag, Vincent; Ardizzoni, Andrea; Planchard, David; Soria, Jean-Charles; Barlesi, Fabrice; Besse, Benjamin
Anti-TIGIT therapies for solid tumors: a systematic review
2023 Rousseau, A; Parisi, C; Barlesi, F
Antibody drug conjugates in older patients: State of the art
2024 Rached, Layal; Geraud, Arthur; Frelaut, Maxime; Ap Thomas, Zoe; Goldschmidt, Vincent; Beraud-Chaulet, Geoffroy; Nagera-Lazarovici, Celine; Danlos, Francois-Xavier; Henon, Clemence; Parisi, Claudia; Gazzah, Anas; Bahleda, Rastilav; Postel Vinay, Sophie; Smolenschi, Cristina; Hollebecque, Antoine; Michot, Jean-Marie; Ribrag, Vincent; Loriot, Yohann; Champiat, Stephane; Ouali, Kaissa; Massard, Christophe; Ponce Aix, Santiago; Bringuier, Michael; Baldini, Capucine
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
2020 Lamberti, G.; Andrini, E.; Sisi, M.; Rizzo, A.; Parisi, C.; Di Federico, A.; Gelsomino, F.; Ardizzoni, A.
BRAF in non–small cell lung cancer: From molecular mechanisms to clinical practice
2025 Parisi, Claudia; Planchard, David
Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications
2023 Parisi, Claudia; Tagliamento, Marco; Belcaid, Laila; Aldea, Mihaela; Bayle, Arnaud; Remon-Masip, Jordi; Italiano, Antoine; Planchard, David; Besse, Benjamin; Barlesi, Fabrice
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer
2025 Rousseau, Adrien; Simon-Tillaux, Noémie; Michiels, Stefan; Derosa, Lisa; Laparra, Ariane; Planchard, David; Remon, Jordi; Barlesi, Fabrice; Lavaud, Pernelle; Frelaut, Maxime; Parisi, Claudia; Gazzah, Anas; Besse, Benjamin; Foulon, Stéphanie
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study
2020 Minari, R.; Mazzaschi, G.; Bordi, P.; Gnetti, L.; Alberti, G.; Altimari, A.; Gruppioni, E.; Sperandi, F.; Parisi, C.; Guaitoli, G.; Bettelli, S.; Longo, L.; Bertolini, F.; Pagano, M.; Bonelli, C.; Tagliavini, E.; Nicoli, D.; Ubiali, A.; Zangrandi, A.; Trubini, S.; Proietto, M.; Fiorentino, M.; Tiseo, M.
Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report
2024 De Giglio, Andrea; Zacchini, Federico; Venturi, Giulia; Di Federico, Alessandro; Parisi, Claudia; Dall'Olio, Filippo Gustavo; Ricciotti, Ilaria; Favorito, Valentina; Gagliano, Ambrogio; De Biase, Dario; Maloberti, Thais; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Melotti, Barbara; Sperandi, Francesca; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea
Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
2020 Parisi, C.; Lamberti, G.; Zompatori, M.; Gelsomino, F.; Salvagni, S.; Sperandi, F.; Ardizzoni, A.
Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review
2024 Mathiot, Laurent; Baldini, Capucine; Letissier, Octave; Hollebecque, Antoine; Bahleda, Rastislav; Gazzah, Anas; Smolenschi, Cristina; Sakkal, Madona; Danlos, François-Xavier; Henon, Clémence; Beshiri, Kristi; Goldschmidt, Vincent; Parisi, Claudia; Patrikidou, Anna; Michot, Jean-Marie; Marabelle, Aurélien; Postel-Vinay, Sophie; Bernard-Tessier, Alice; Loriot, Yohann; Ponce, Santiago; Champiat, Stéphane; Ouali, Kaïssa
Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors
2020 Tateo, V.; Manuzzi, L.; De Giglio, A.; Parisi, C.; Lamberti, G.; Campana, D.; Pantaleo, M. A.
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
2024 Parisi, Claudia; Abdayem, Pamela; Tagliamento, Marco; Besse, Benjamin; Planchard, David; Remon, Jordi; Minuti, Gabriele; Cappuzzo, Federico; Barlesi, Fabrice
PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy
2021 Di Federico, A.; De Giglio, A.; Parisi, C.; Gelsomino, F.; Ardizzoni, A.
Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms
2025 Marinello, Arianna; Parisi, Claudia; Vasseur, Damien; Combarel, David; Bihoreau, Juliette; Lavaud, Pernelle; Ezzedine, Rémy; Zullo, Lodovica; Friboulet, Luc; Zalcman, Gerard; Italiano, Antoine; Besse, Benjamin; Aldea, Mihaela
STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status
2025 De Giglio, Andrea; De Biase, Dario; Favorito, Valentina; Maloberti, Thais; Di Federico, Alessandro; Zacchini, Federico; Venturi, Giulia; Parisi, Claudia; Gustavo Dall'Olio, Filippo; Ricciotti, Ilaria; Gagliano, Ambrogio; Melotti, Barbara; Sperandi, Francesca; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea
STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
2021 Di Federico, Alessandro; De Giglio, Andrea; Parisi, Claudia; Gelsomino, Francesco
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)
2023 Parisi, Claudia; Mahjoubi, Linda; Gazzah, Anas; Barlesi, Fabrice
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances | 2021 | Tateo, V.; Manuzzi, L.; Parisi, C.; De Giglio, A.; Campana, D.; Pantaleo, M. A.; Lamberti, G. | |
| Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience | 2024 | Parisi, Claudia; Carlos Benitez, José; Lecourt, Hélène; Gustavo Dall'Olio, Filippo; Aldea, Mihaela; Blanc-Durand, Felix; Vergé, Véronique; Quivoron, Cyril; Naltet, Charles; Abdayem, Pamela; Lavaud, Pernelle; Rosa Ghigna, Maria; Friboulet, Luc; Loriot, Yohann; De Botton, Stéphane; Ribrag, Vincent; Ardizzoni, Andrea; Planchard, David; Soria, Jean-Charles; Barlesi, Fabrice; Besse, Benjamin | |
| Anti-TIGIT therapies for solid tumors: a systematic review | 2023 | Rousseau, A; Parisi, C; Barlesi, F | |
| Antibody drug conjugates in older patients: State of the art | 2024 | Rached, Layal; Geraud, Arthur; Frelaut, Maxime; Ap Thomas, Zoe; Goldschmidt, Vincent; Beraud-Chaulet, Geoffroy; Nagera-Lazarovici, Celine; Danlos, Francois-Xavier; Henon, Clemence; Parisi, Claudia; Gazzah, Anas; Bahleda, Rastilav; Postel Vinay, Sophie; Smolenschi, Cristina; Hollebecque, Antoine; Michot, Jean-Marie; Ribrag, Vincent; Loriot, Yohann; Champiat, Stephane; Ouali, Kaissa; Massard, Christophe; Ponce Aix, Santiago; Bringuier, Michael; Baldini, Capucine | |
| Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma | 2020 | Lamberti, G.; Andrini, E.; Sisi, M.; Rizzo, A.; Parisi, C.; Di Federico, A.; Gelsomino, F.; Ardizzoni, A. | |
| BRAF in non–small cell lung cancer: From molecular mechanisms to clinical practice | 2025 | Parisi, Claudia; Planchard, David | |
| Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications | 2023 | Parisi, Claudia; Tagliamento, Marco; Belcaid, Laila; Aldea, Mihaela; Bayle, Arnaud; Remon-Masip, Jordi; Italiano, Antoine; Planchard, David; Besse, Benjamin; Barlesi, Fabrice | |
| Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer | 2025 | Rousseau, Adrien; Simon-Tillaux, Noémie; Michiels, Stefan; Derosa, Lisa; Laparra, Ariane; Planchard, David; Remon, Jordi; Barlesi, Fabrice; Lavaud, Pernelle; Frelaut, Maxime; Parisi, Claudia; Gazzah, Anas; Besse, Benjamin; Foulon, Stéphanie | |
| Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study | 2020 | Minari, R.; Mazzaschi, G.; Bordi, P.; Gnetti, L.; Alberti, G.; Altimari, A.; Gruppioni, E.; Sperandi, F.; Parisi, C.; Guaitoli, G.; Bettelli, S.; Longo, L.; Bertolini, F.; Pagano, M.; Bonelli, C.; Tagliavini, E.; Nicoli, D.; Ubiali, A.; Zangrandi, A.; Trubini, S.; Proietto, M.; Fiorentino, M.; Tiseo, M. | |
| Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report | 2024 | De Giglio, Andrea; Zacchini, Federico; Venturi, Giulia; Di Federico, Alessandro; Parisi, Claudia; Dall'Olio, Filippo Gustavo; Ricciotti, Ilaria; Favorito, Valentina; Gagliano, Ambrogio; De Biase, Dario; Maloberti, Thais; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Melotti, Barbara; Sperandi, Francesca; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea | |
| Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer | 2020 | Parisi, C.; Lamberti, G.; Zompatori, M.; Gelsomino, F.; Salvagni, S.; Sperandi, F.; Ardizzoni, A. | |
| Exploring the Role of Target Expression in Treatment Efficacy of Antibody-Drug Conjugates (ADCs) in Solid Cancers: A Comprehensive Review | 2024 | Mathiot, Laurent; Baldini, Capucine; Letissier, Octave; Hollebecque, Antoine; Bahleda, Rastislav; Gazzah, Anas; Smolenschi, Cristina; Sakkal, Madona; Danlos, François-Xavier; Henon, Clémence; Beshiri, Kristi; Goldschmidt, Vincent; Parisi, Claudia; Patrikidou, Anna; Michot, Jean-Marie; Marabelle, Aurélien; Postel-Vinay, Sophie; Bernard-Tessier, Alice; Loriot, Yohann; Ponce, Santiago; Champiat, Stéphane; Ouali, Kaïssa | |
| Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors | 2020 | Tateo, V.; Manuzzi, L.; De Giglio, A.; Parisi, C.; Lamberti, G.; Campana, D.; Pantaleo, M. A. | |
| Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives | 2024 | Parisi, Claudia; Abdayem, Pamela; Tagliamento, Marco; Besse, Benjamin; Planchard, David; Remon, Jordi; Minuti, Gabriele; Cappuzzo, Federico; Barlesi, Fabrice | |
| PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy | 2021 | Di Federico, A.; De Giglio, A.; Parisi, C.; Gelsomino, F.; Ardizzoni, A. | |
| Personalized Therapy in a Patient With EGFR-Mutated NSCLC Developing Sequential CCDC6-RET Fusion and BRAF V600E Mutation as Bypass Resistance Mechanisms | 2025 | Marinello, Arianna; Parisi, Claudia; Vasseur, Damien; Combarel, David; Bihoreau, Juliette; Lavaud, Pernelle; Ezzedine, Rémy; Zullo, Lodovica; Friboulet, Luc; Zalcman, Gerard; Italiano, Antoine; Besse, Benjamin; Aldea, Mihaela | |
| STK11 mutations correlate with poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemo-immunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status | 2025 | De Giglio, Andrea; De Biase, Dario; Favorito, Valentina; Maloberti, Thais; Di Federico, Alessandro; Zacchini, Federico; Venturi, Giulia; Parisi, Claudia; Gustavo Dall'Olio, Filippo; Ricciotti, Ilaria; Gagliano, Ambrogio; Melotti, Barbara; Sperandi, Francesca; Altimari, Annalisa; Gruppioni, Elisa; Tallini, Giovanni; Gelsomino, Francesco; Montanaro, Lorenzo; Ardizzoni, Andrea | |
| STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive? | 2021 | Di Federico, Alessandro; De Giglio, Andrea; Parisi, Claudia; Gelsomino, Francesco | |
| TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC) | 2023 | Parisi, Claudia; Mahjoubi, Linda; Gazzah, Anas; Barlesi, Fabrice |